These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of losartan on the treatment of posttransplant erythrocytosis.
    Author: Navarro JF, García J, Macía M, Mora C, Chahin J, Gallego E, Méndez ML, del Castillo N.
    Journal: Clin Nephrol; 1998 Jun; 49(6):370-2. PubMed ID: 9696433.
    Abstract:
    Erythrocytosis is a relatively common complication of renal transplantation. Recent observations indicate that angiotensin-converting enzyme inhibitors correct renal transplant erythrocytosis. Other drugs to inhibit the renin-angiotensin system have been developed recently. The newest of these is losartan, a specific antagonist of the angiotensin II type I receptor. We report three patients in which the use of losartan controlled posttransplant erythrocytosis. Our findings suggest that losartan can be effective and safe in the treatment of posttransplant erythrocytosis.
    [Abstract] [Full Text] [Related] [New Search]